Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

445 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. Among authors: vilsboll t. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.
The alpha-cell as target for type 2 diabetes therapy.
Christensen M, Bagger JI, Vilsbøll T, Knop FK. Christensen M, et al. Among authors: vilsboll t. Rev Diabet Stud. 2011 Fall;8(3):369-81. doi: 10.1900/RDS.2011.8.369. Epub 2011 Nov 10. Rev Diabet Stud. 2011. PMID: 22262074 Free PMC article. Review.
The effect of glucagon-like peptide 1 on cardiovascular risk.
Sivertsen J, Rosenmeier J, Holst JJ, Vilsbøll T. Sivertsen J, et al. Among authors: vilsboll t. Nat Rev Cardiol. 2012 Jan 31;9(4):209-22. doi: 10.1038/nrcardio.2011.211. Nat Rev Cardiol. 2012. PMID: 22290234 Review.
Glucagon and type 2 diabetes: the return of the alpha cell.
Lund A, Bagger JI, Christensen M, Knop FK, Vilsbøll T. Lund A, et al. Among authors: vilsboll t. Curr Diab Rep. 2014 Dec;14(12):555. doi: 10.1007/s11892-014-0555-4. Curr Diab Rep. 2014. PMID: 25344790 Review.
A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes.
Ampudia-Blasco FJ, Benhamou PY, Charpentier G, Consoli A, Diamant M, Gallwitz B, Khunti K, Mathieu C, Ridderstråle M, Seufert J, Tack C, Vilsbøll T, Phan TM, Stoevelaar H. Ampudia-Blasco FJ, et al. Among authors: vilsboll t. Diabetes Technol Ther. 2015 Mar;17(3):194-202. doi: 10.1089/dia.2014.0260. Epub 2014 Oct 27. Diabetes Technol Ther. 2015. PMID: 25347226 Free PMC article.
445 results